| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |